Bank of America
FLGT icon

Bank of America’s Fulgent Genetics FLGT Stock Holding History

Bank of America’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-900
Closed -$17.9K – 8437
2025
Q2 		$17.9K Buy
+900
New +$17.5K ﹤0.01% 7078

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America's FLGT Position: Q1 2026 in Review

Bank of America reduced its Fulgent Genetics (FLGT) stake by 21% in Q1 2026, selling an estimated $701K and leaving 120,583 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #4144.

Bank of America first reported a position in FLGT in Q4 2016 and has held it in 29 quarters since. The position peaked at $4.36M in Q1 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Bank of America held 120,583 shares of Fulgent Genetics worth $1.92M as of Q1 2026.
  • Bank of America sold 32,319 Fulgent Genetics shares in Q1 2026, an estimated $701K.
  • Fulgent Genetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4144 holding.
  • Bank of America first reported a position in Fulgent Genetics in Q4 2016 and has held it in 29 quarters since.
  • Bank of America's Fulgent Genetics position peaked at $4.36M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.